Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Global Cancer Incidence and Screening, Prostate Cancer Diagnosis and Treatment, Colorectal Cancer Screening and Detection, and Fluorine in Organic Chemistry.
What can patient-reported experience measures tell us about the variation in patients’ experience of prostate cancer care? A cross-sectional study using survey data from the National Prostate Cancer Audit in England
Prostate cancer outcomes following whole‐gland and focal high‐intensity focused ultrasound
Variations in the Type of Adjuvant Chemotherapy Among Stage III Colon Cancer Patients in England
Organisation and delivery of supportive services for patients with prostate cancer in the National Health Service in England and Wales: a national cross-sectional hospital survey and latent class analysis
Impact of the COVID‐19 pandemic on the diagnosis and treatment of men with prostate cancer
A low prostate specific antigen predicts a worse outcome in high but not in low/intermediate-grade prostate cancer
Comparison of the treatment of men with prostate cancer between the US and England: an international population-based study
Interventions for obstructive uropathy in advanced prostate cancer: a population‐based study
Practicalities, challenges and solutions to delivering a national organisational survey of cancer service and processes: Lessons from the National Prostate Cancer Audit
Urinary incontinence and use of incontinence surgery after radical prostatectomy: a national study using patient‐reported outcomes
Are socio-economic inequalities in breast cancer survival explained by peri-diagnostic factors?
Exploring the Role of Leadership in Facilitating Change to Improve Cancer Survival: An Analysis of Experiences in Seven High Income Countries in the International Cancer Benchmarking Partnership (ICBP)
Determinants of variation in radical local treatment for men with high-risk localised or locally advanced prostate cancer in England
Hospital volume and outcomes after radical prostatectomy: a national population-based study using patient-reported urinary continence and sexual function
The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study
Impact of High-Dose-Rate and Low-Dose-Rate Brachytherapy Boost on Toxicity, Functional and Cancer Outcomes in Patients Receiving External Beam Radiation Therapy for Prostate Cancer: A National Population-Based Study
"There’s Not Enough Bodies to Do the Demand:" An Exploration of Key Stakeholder Views on the Role of Health Service Capacity in Shaping Cancer Outcomes in 7 International Cancer Benchmarking Partnership Countries
Fleshing out the data: when epidemiological researchers engage with patients and carers. Learning lessons from a patient involvement activity
Racial/ethnic and socioeconomic survival disparities for children and adolescents with central nervous system tumours in the United States, 2000–2015
Surgical treatment and survival from colorectal cancer in Denmark, England, Norway, and Sweden: a population-based study
Can we assess Cancer Waiting Time targets with cancer survival? A population-based study of individually linked data from the National Cancer Waiting Times monitoring dataset in England, 2009-2013
Characteristics of patients with missing information on stage: a population-based study of patients diagnosed with colon, lung or breast cancer in England in 2013
Which patients are not included in the English Cancer Waiting Times monitoring dataset, 2009–2013? Implications for use of the data in research
Do pre-diagnosis primary care consultation patterns explain deprivation-specific differences in net survival among women with breast cancer? An examination of individually-linked data from the UK West Midlands cancer registry, national screening programme and Clinical Practice Research Datalink
What might explain deprivation-specific differences in the excess hazard of breast cancer death amongst screen-detected women? Analysis of patients diagnosed in the West Midlands region of England from 1989 to 2011
No ‘cure’ within 12 years of diagnosis among breast cancer patients who are diagnosed via mammographic screening: women diagnosed in the West Midlands region of England 1989–2011
Do cancer survival statistics for every hospital make sense?
Ethnicity, deprivation and screening: survival from breast cancer among screening-eligible women in the West Midlands diagnosed from 1989 to 2011